Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31M Sell
9,181
-18
-0.2% -$3.87K 0.53% 46
2026
Q1
$2M Buy
9,199
+279
+3% +$61.9K 0.52% 48
2025
Q4
$2.04M Sell
8,920
-62
-0.7% -$14.1K 0.56% 44
2025
Q3
$2.08M Sell
8,982
-228
-2% -$46.4K 0.6% 43
2025
Q2
$1.71M Buy
9,210
+19
+0.2% +$3.53K 0.54% 47
2025
Q1
$1.93M Sell
9,191
-135
-1% -$26.2K 0.63% 37
2024
Q4
$1.66M Sell
9,326
-229
-2% -$42.1K 0.58% 41
2024
Q3
$1.89M Sell
9,555
-123
-1% -$23K 0.69% 34
2024
Q2
$1.66M Sell
9,678
-312
-3% -$51.7K 0.68% 36
2024
Q1
$1.82M Buy
9,990
+81
+0.8% +$14K 0.8% 31
2023
Q4
$1.54M Buy
9,909
+12
+0.1% +$1.75K 0.77% 31
2023
Q3
$1.48M Sell
9,897
-2,847
-22% -$418K 0.81% 31
2023
Q2
$1.72M Sell
12,744
-177
-1% -$26K 0.93% 25
2023
Q1
$2.06M Buy
12,921
+2,404
+23% +$368K 1.18% 19
2022
Q4
$1.7M Buy
10,517
+15
+0.1% +$2.3K 1.05% 21
2022
Q3
$1.41M Sell
10,502
-80
-0.8% -$11.5K 0.99% 22
2022
Q2
$1.62M Sell
10,582
-205
-2% -$31.3K 1.13% 16
2022
Q1
$1.75M Buy
10,787
+200
+2% +$29.1K 1.06% 20
2021
Q4
$1.43M Buy
+10,587
New +$1.25M 0.88% 22

Other funds holding ABBV

City State Bank's ABBV Position: Q2 2026 in Review

City State Bank reduced its AbbVie (ABBV) stake by 0.2% in Q2 2026, selling an estimated $3.87K and leaving 9,181 shares worth $2.31M. The position accounts for 0.53% of the portfolio, ranked #46.

City State Bank first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • City State Bank held 9,181 shares of AbbVie worth $2.31M as of Q2 2026.
  • City State Bank sold 18 AbbVie shares in Q2 2026, an estimated $3.87K.
  • AbbVie made up 0.53% of City State Bank's portfolio in Q2 2026, its #46 holding.
  • City State Bank first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.